Jupiter Asset Management Ltd. Buys New Shares in The Clorox Company $CLX

Jupiter Asset Management Ltd. purchased a new position in shares of The Clorox Company (NYSE:CLX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,080 shares of the company’s stock, valued at approximately $250,000.

Several other hedge funds and other institutional investors have also made changes to their positions in CLX. Simplicity Wealth LLC lifted its position in shares of Clorox by 157.3% during the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,198 shares during the last quarter. Raymond James Financial Inc. raised its stake in Clorox by 15.6% in the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock valued at $39,747,000 after buying an additional 36,352 shares in the last quarter. Nuance Investments LLC lifted its holdings in Clorox by 182.5% during the 2nd quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock worth $101,832,000 after buying an additional 547,839 shares during the last quarter. Nordea Investment Management AB boosted its position in shares of Clorox by 16.3% during the 2nd quarter. Nordea Investment Management AB now owns 484,352 shares of the company’s stock worth $57,827,000 after acquiring an additional 68,026 shares in the last quarter. Finally, AlphaQuest LLC increased its holdings in shares of Clorox by 109.4% in the 1st quarter. AlphaQuest LLC now owns 11,873 shares of the company’s stock valued at $1,748,000 after acquiring an additional 6,203 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Stock Down 0.7%

Shares of NYSE:CLX opened at $103.52 on Friday. The Clorox Company has a 1-year low of $103.43 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The stock has a market cap of $12.63 billion, a P/E ratio of 15.88, a P/E/G ratio of 0.92 and a beta of 0.52. The firm has a fifty day moving average price of $117.67 and a 200 day moving average price of $123.73.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the previous year, the business posted $1.86 earnings per share. Clorox’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd were given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CLX. Wells Fargo & Company decreased their target price on Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. BNP Paribas Exane reduced their price objective on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating for the company in a research report on Tuesday, November 4th. Bank of America lowered their target price on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Morgan Stanley cut their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Finally, Rothschild & Co Redburn decreased their price objective on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $125.69.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.